Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026)

Hims & Hers Health's Amortization of Deferred Charges history spans 4 years, with the latest figure at $1.7 million for Q1 2026.

On a quarterly basis, Amortization of Deferred Charges changed N/A to $1.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.0 million, a N/A change, with the full-year FY2025 number at $4.5 million, changed N/A from a year prior.
Amortization of Deferred Charges hit $1.7 million in Q1 2026 for Hims & Hers Health, down from $1.7 million in the prior quarter.
Over the last five years, Amortization of Deferred Charges for HIMS hit a ceiling of $1.7 million in Q4 2025 and a floor of $1.6 million in Q3 2025.